HeartCare-B (06609.HK) Receives NMPA Approval for Embolic Coil Registration

HeartCare-B(06609) announced that it has recently received approval from the National Medical Products Administration (NMPA) for the registration application of embolic coils. As a result, embolic coils have become the company's 11th neurointerventional product approved by the NMPA.

As of the date of this announcement, the company has obtained NMPA-approved products in all four fields of the neurointerventional treatment device market, including ischemic stroke thrombectomy devices, intracranial artery stenosis treatment devices, hemorrhagic stroke treatment devices, and vascular access devices.